Phase 1 Von Willebrand Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3Concomitant VWD and Hemophilia

Bleeding and Clotting Disorders Institute Peoria, Illinois40 enrolled12 locationsNCT05500807

Recruiting

Phase 1Phase 2

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

Von Willebrand Diseases

Vega Therapeutics, Inc116 enrolled25 locationsNCT05776069